시장보고서
상품코드
2048771

제대혈 은행 시장 규모, 점유율, 성장 분석 : 보존 방법별, 서비스 유형별, 성분 유형별, 용도별, 치료 용도별, 최종사용자별, 소유 모델별, 지역별 - 업계 예측(2026-2033년)

Cord Blood Banking Market Size, Share, and Growth Analysis, By Storage Type, By Service Type, By Component Type, By Application, By Therapeutic Use, By End User, By Ownership Model, By Region - Industry Forecast 2026-2033

발행일: | 리서치사: 구분자 SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,300 금액 안내 화살표 ₩ 8,171,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 금액 안내 화살표 ₩ 9,559,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 금액 안내 화살표 ₩ 10,946,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 제대혈 은행 시장 규모는 2024년에 258억 달러로 평가되었으며, 2025년 273억 달러에서 2033년까지 428억 5,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 5.8%로 성장할 것으로 전망됩니다.

세계 제대혈 은행 시장은 조혈모세포 및 재생의료용 세포 치료에 대한 수요 증가에 힘입어 괄목할 만한 성장을 거듭하고 있습니다. 이러한 확장은 조사의 발전, 대중의 인식 향상, 그리고 혁신적인 파트너십의 영향을 받아 틈새 서비스에서 상업적 시장으로 변모하고 있습니다. 제대혈 은행은 제대혈의 채취, 처리 및 장기 보관을 지원하고 있습니다. 제대혈에는 조혈모세포가 풍부하게 함유되어 있어 혈액암 및 유전성 질환의 치료와 재생의료의 실험적 치료에 사용됩니다. 임상시험의 증가는 비혈액계 악성 종양 치료에서 제대혈 유닛의 잠재력을 부각시키고 있습니다. 이러한 모멘텀은 병원과 보험회사들이 제대혈 은행을 지원하도록 유도하고, 인프라에 대한 투자 확대, 처리 기준 개선, 가격 인하로 이어져 궁극적으로 전 세계적으로 필수적인 치료에 대한 접근성을 확대할 수 있을 것입니다.

세계 제대혈 은행 시장의 성장요인

제대혈 은행 세계 시장은 제대혈의 많은 이점에 대한 환자와 의료진들의 인식이 높아짐에 따라 호황을 누리고 있습니다. 이러한 이해는 제대혈 보존에 대한 수용을 촉진하고, 미래의 의료적 활용을 위해 더 많은 부모들이 적극적으로 제대혈을 채취하고 안전하게 보존하는 것을 촉진하고 있습니다. 제대혈의 치료 가능성이 알려지면서 부모와 의료진 모두 제대혈을 현실적인 치료 옵션으로 인식하고 있으며, 이에 따라 제대혈의 저장 능력과 서비스 제공을 확대하기 위한 투자가 이루어지고 있습니다. 또한, 교육 강화와 정보 접근성 향상을 통해 은행은 신뢰와 신용을 쌓고 영향력을 확대하는 동시에 임상 파트너십을 구축하고 있습니다. 이러한 것들이 맞물려 시장 확대와 서비스 다양화를 견인하고 있습니다.

세계 제대혈 은행 시장의 억제요인

세계 제대혈 은행 시장의 성장은 높은 운영 비용과 컴플라이언스 비용으로 인해 큰 도전에 직면해 있습니다. 전문적인 인프라 구축과 더불어 숙련된 인력과 강력한 품질 관리 시스템의 필요성은 운영의 복잡성과 비용을 더욱 증가시키고 있습니다. 이러한 상황은 지리적 확장이나 기술 이외의 분야에 대한 투자를 저해하고 있으며, 특히 소규모 사업자들이 이 분야에 진입하는 것을 어렵게 만들고 있습니다. 또한, 이러한 비용으로 인한 재정적 부담은 종종 소비자에게 서비스 요금 인상으로 이어져 서비스 이용을 주저하게 만드는 요인이 되고, 궁극적으로 시장 침투율과 경쟁 역학에 영향을 미칠 수 있습니다.

세계 제대혈 은행 시장 동향

전 세계 제대혈 은행 시장은 보존된 제대혈 유닛의 임상 및 연구 용도 확대에 힘입어 괄목할 만한 성장을 거듭하고 있습니다. 제대혈 은행, 학술기관, 생명공학 기업 간의 협력 강화로 혁신적인 중개연구와 새로운 세포 치료제 개발이 촉진되고 있습니다. 의료진이 새로운 적응증과 임상시험 프로토콜을 모색하는 가운데, 고품질의 표준화된 뱅킹 서비스에 대한 수요가 급증하고 있습니다. 이러한 추세에 따라 제대혈 은행은 맞춤형 의료 및 재생의료 분야의 전략적 자산으로 자리매김하고 있으며, 치료용 및 실험용에 특화된 독자적인 바이오뱅킹 전략을 추진함으로써 재생의료 솔루션의 전반적인 전망을 향상시키고 있습니다.

자주 묻는 질문

  • 세계 제대혈 은행 시장 규모는 어떻게 되며, 향후 성장 전망은 어떤가요?
  • 세계 제대혈 은행 시장의 성장 요인은 무엇인가요?
  • 세계 제대혈 은행 시장의 억제 요인은 무엇인가요?
  • 세계 제대혈 은행 시장의 동향은 어떻게 변화하고 있나요?
  • 세계 제대혈 은행 시장에서 주요 기업은 어디인가요?

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

세계의 제대혈 은행 시장 규모 : 보존 방법별

세계의 제대혈 은행 시장 규모 : 서비스 유형별

세계의 제대혈 은행 시장 규모 : 성분 유형별

세계의 제대혈 은행 시장 규모 : 용도별

세계의 제대혈 은행 시장 규모 : 치료 용도별

세계의 제대혈 은행 시장 규모 : 최종사용자별

세계의 제대혈 은행 시장 규모 : 소유 모델별

세계의 제대혈 은행 시장 규모 : 지역별

경쟁 정보

주요 기업 개요

결론과 제안

KSM 26.06.08

Global Cord Blood Banking Market size was valued at USD 25.8 Billion in 2024 and is poised to grow from USD 27.3 Billion in 2025 to USD 42.85 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global cord blood banking market is experiencing significant growth driven by the rising demand for hematopoietic and regenerative cell therapies. This expansion has transformed the industry from a niche service to a commercially viable marketplace, influenced by advancements in research, heightened public awareness, and innovative partnerships. Cord blood banks facilitate the collection, processing, and long-term storage of umbilical cord blood, primarily rich in hematopoietic stem cells used for treating blood cancers and genetic disorders, alongside experimental therapies in regenerative medicine. The increasing volume of clinical trials highlights the potential of cord blood units in treating non-hematological malignancies. This momentum will encourage hospitals and insurers to support cord blood banking, leading to enhanced infrastructure investment, better processing standards, and more affordable prices, ultimately expanding access to essential treatments globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cord Blood Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cord Blood Banking Market Segments Analysis

Global cord blood banking market is segmented by storage type, service type, component type, application, therapeutic use, end user, ownership model and region. Based on storage type, the market is segmented into private cord blood banking, public cord blood banking and hybrid cord blood banking. Based on service type, the market is segmented into collection & transportation services, processing services, cryopreservation & storage services, testing & screening services and retrieval & transplantation support services. Based on component type, the market is segmented into cord blood, cord tissue, placental blood and stem cell expansion & derived products. Based on application, the market is segmented into hematological disorders, oncology & cancer treatment, immune disorders, metabolic disorders, genetic disorders, regenerative medicine, neurological disorders and others. Based on therapeutic use, the market is segmented into allogeneic transplantation, autologous transplantation and research use. Based on end user, the market is segmented into hospitals & transplant centers, research institutes & universities, biotechnology & pharmaceutical companies and specialty clinics. Based on ownership model, the market is segmented into standalone cord blood banks, hospital-integrated cord blood banks and multi-service biobanks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cord Blood Banking Market

The global market for cord blood banking is thriving due to heightened awareness among patients and healthcare providers regarding the numerous benefits of cord blood. This understanding has fostered greater acceptance of cord blood storage, prompting more parents to proactively collect and securely store it for potential future medical uses. As the therapeutic potential of cord blood gains recognition, both parents and healthcare professionals are increasingly viewing it as a viable treatment option, leading to an investment in enhanced storage capabilities and service offerings. Additionally, through improved education and access to information, banks have built trust and credibility, allowing them to broaden their reach and forge clinical partnerships that collectively drive market expansion and service diversification.

Restraints in the Global Cord Blood Banking Market

The growth of the global cord blood banking market faces significant challenges due to high operating and compliance costs. Establishing a specialized infrastructure, along with the need for trained personnel and robust quality management systems, adds layers of operational complexity and expense. This situation discourages investment in geographical expansion and non-technological advancements, making it particularly difficult for smaller providers to enter this sector. Furthermore, the financial burden created by these costs often translates into higher service fees for consumers, which can dissuade them from utilizing these services, ultimately affecting market penetration and competitive dynamics.

Market Trends of the Global Cord Blood Banking Market

The Global Cord Blood Banking market is experiencing significant growth driven by the expanding clinical and research applications for stored cord blood units. Increased collaboration among cord blood banks, academic institutions, and biotechnology firms is facilitating innovative translational research and the development of novel cell-based therapies. As healthcare professionals explore new indications and investigational protocols, the demand for high-quality, standardized banking services is surging. This trend positions cord blood banks as strategic assets in personalized and regenerative medicine, promoting unique biobanking strategies tailored for therapeutic and experimental use, thereby enhancing the overall landscape of regenerative healthcare solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Cord Blood Banking Market Size by Storage Type & CAGR (2026-2033)

  • Market Overview
  • Private Cord Blood Banking
  • Public Cord Blood Banking
  • Hybrid Cord Blood Banking

Global Cord Blood Banking Market Size by Service Type & CAGR (2026-2033)

  • Market Overview
  • Collection & Transportation Services
  • Processing Services
  • Cryopreservation & Storage Services
  • Testing & Screening Services
  • Retrieval & Transplantation Support Services

Global Cord Blood Banking Market Size by Component Type & CAGR (2026-2033)

  • Market Overview
  • Cord Blood
  • Cord Tissue
  • Placental Blood
  • Stem Cell Expansion & Derived Products

Global Cord Blood Banking Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Hematological Disorders
  • Oncology & Cancer Treatment
  • Immune Disorders
  • Metabolic Disorders
  • Genetic Disorders
  • Regenerative Medicine
  • Neurological Disorders
  • Others

Global Cord Blood Banking Market Size by Therapeutic Use & CAGR (2026-2033)

  • Market Overview
  • Allogeneic Transplantation
  • Autologous Transplantation
  • Research Use

Global Cord Blood Banking Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Transplant Centers
  • Research Institutes & Universities
  • Biotechnology & Pharmaceutical Companies
  • Specialty Clinics

Global Cord Blood Banking Market Size by Ownership Model & CAGR (2026-2033)

  • Market Overview
  • Standalone Cord Blood Banks
  • Hospital-Integrated Cord Blood Banks
  • Multi-Service Biobanks

Global Cord Blood Banking Market Size & CAGR (2026-2033)

  • North America (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
    • US
    • Canada
  • Europe (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Cordlife Group Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cryo-Cell International, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CBR Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Global Cord Blood Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • StemCyte, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Americord Registry LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FamiCord Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vita 34 AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeCell International Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cryoviva Biotech Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smart Cells International Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AlphaCord LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ViaCord, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • California Cryobank Stem Cell Services LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • China Cord Blood Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boyalife Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medipost Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Singapore Cord Blood Bank
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canadian Blood Services
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NMDP BioTherapies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기